[1]
“Associations of Cutaneous Immune-Related Adverse Effects of Immunotherapy With Treatment Response in Patients With Metastatic Melanoma”, J of Skin, vol. 5, no. 2, pp. 108–117, Mar. 2021, doi: 10.25251/skin.5.2.5.